Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Carcinoma, Non-Small-Cell Lung 3Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Leukoplakia, Oral 2Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1Skin Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Liposarcoma, Myxoid 1Liposarcoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Head and Neck Neoplasms 1Carotid Intimal Medial Thickness 1 1Carcinoma, Squamous Cell 1Breast Neoplasms 1

Interventions

Metformin 4Inositol 2salicylsalicylic acid 1maltodextrin 1licogliflozin 1Tooth Exfoliation 1Sodium Salicylate 1Root Planing 1Pioglitazone 1Inulin 1Exercise 1Exenatide 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Insulin Resistance × Pioglitazone × Clear all
NCT04995978 2023-06-23

Insulin Resistance and Androgen Deprivation Therapy

St. Louis University

Phase 2 Withdrawn
Genitourinary

Insulin Resistance, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡